๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Cholinesterase Inhibitors and Alzheimer Disease

โœ Scribed by Maren S. Mayhew

Book ID
113827467
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
109 KB
Volume
6
Category
Article
ISSN
1555-4155

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Initiating and monitoring cholinesterase
Initiating and monitoring cholinesterase inhibitor treatment for Alzheimer's disease
โœ Gregory R. J. Swanwick; Brian A. Lawlor ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 75 KB ๐Ÿ‘ 2 views

The availability of acetylcholinesterase inhibitors for the treatment of Alzheimer's disease raises a number of clinical and ethical questions. Many of the guidelines published in an attempt to tackle these questions lack either clinical or scientiยฎc validity. Against this background a model is prop

Hypertension, white matter change and re
Hypertension, white matter change and response to cholinesterase inhibitors in Alzheimer's disease
โœ Peter J. Connelly; Neil P. Prentice; Kenneth G. Fowler ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 68 KB ๐Ÿ‘ 1 views

Background Cholinesterase inhibitors are used to treat mild to moderate Alzheimer's disease. Their role in patients with concurrent cerebrovascular disease has been less well studied, and the influence of vascular risk factors on response to treatment is uncertain. We investigated the effect of hype